A. Amiel et al., Replication status as a marker for predisposition for lymphoma in patientswith chronic hepatitis C with and without cryoglobulinemia, EXP HEMATOL, 28(2), 2000, pp. 156-160
Objective. Essential mixed cryoglobulinemia (EMC) type ii is associated wit
h hepatitis C virus (HCV) in 90% of the patients with this disorder. A sign
ificant subset of these patients is at risk to develop non-Hodgkin lymphoma
(NHL). The objective of this study was to examine whether the presence of
EMC, a presumably premalignant step of lymphoproliferation, is associated w
ith changes in the replication state of normal structural genes.
Materials and Methods. The study group included three subgroups: (1) seven
patients with HCV without EMC; (2) eight patients with HCV associated with
EMC. 3. Seven patients with follicular lymphoma; and (3) six healthy indivi
duals served as control group. Monocolor fluorescent in situ hybridization
(FISH) with probes to p53, RE-I, and 21q22 was applied to leukocytes nuclei
for the evaluation of replication timing.
Results. Asynchronous replication (SD) rate was similar in patients with NH
L and those with HCV associated with EMC and both are significantly higher
when compared to patients with HCV without EMC and to normal controls (p <
0.01) for each comparison. This held true for all studied loci (21q22, RB-1
, and p53). Patients infected by HCV (but without EMC) had a significantly
higher rate of asynchronous pattern in comparison with healthy controls (p
< 0.01).
Conclusions. Patients with a "premalignant" clinical condition HCV with EMC
already demonstrate asynchronous type of replication which is similar to p
atients who already have an established malignant disease (i.e., NHL), In t
he future, replication may be used to assess the risk of malignant transfor
mation in patients with "benign" proliferation. (C) 2000 International Soci
ety for Experimental Hematology. Published by Elsevier Science Inc.